{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:33:56Z","timestamp":1792773236932,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.jcrc.2026.155750","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:22:17Z","timestamp":1790068937000},"page":"155750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative efficacy and safety of hydrocortisone-based regimens in septic shock: A network meta-analysis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6664-6129","authenticated-orcid":false,"given":"Sehyun","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-5514","authenticated-orcid":false,"given":"Sang Gyu","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-1381","authenticated-orcid":false,"given":"Hyo-Lim","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcrc.2026.155750_bb0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2026.155750_bb0010","series-title":"Harrison's Principles of Internal Medicine, 21e","author":"Brant","year":"2025"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/rccm.201403-0471OC","article-title":"Increased 1-year healthcare use in survivors of severe sepsis","volume":"190","author":"Prescott","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155750_bb0020","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155750_bb0025","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155750_bb0030","series-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock","author":"Prescott","year":"2026"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155750_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155750_bb0040","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering","year":"1995","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155750_bb0045","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155750_bb0050","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.ajem.2018.11.040","article-title":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis","volume":"37","author":"Ni","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155750_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with Sepsis: a systematic review and meta-analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"7464","key":"10.1016\/j.jcrc.2026.155750_bb0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.38181.482222.55","article-title":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis","volume":"329","author":"Annane","year":"2004","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155750_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155750_bb0070","article-title":"Corticosteroids for treating sepsis in adult patients: a systematic review and meta-analysis","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcrc.2026.155750_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcrc.2018.09.013","article-title":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock - a meta-analysis of randomized controlled trials and trial sequential analysis","volume":"48","author":"Zhou","year":"2018","journal-title":"J Crit Care"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/ajm.AJM_97_19","article-title":"Combination of low-dose glucocorticosteroids and mineralocorticoids as adjunct therapy for adult patients with septic shock: a systematic review and meta-analysis of randomized trials and observational studies","volume":"9","author":"Archontakis Barakakis","year":"2019","journal-title":"Avicenna J Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155750_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s15010-024-02381-z","article-title":"Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis","volume":"53","author":"Wu","year":"2025","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0090","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/CCM.0000000000006161","volume":"52","author":"Lai","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155750_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155750_bb0100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155750_bb0105","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/01.CCM.0000233872.04706.BB","article-title":"Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria","volume":"34","author":"Rinaldi","year":"2006","journal-title":"Crit Care Med"},{"issue":"17","key":"10.1016\/j.jcrc.2026.155750_bb0110","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis the HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155750_bb0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155750_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155750_bb0125","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial","volume":"35","author":"Lv","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155750_bb0130","first-page":"11","article-title":"Early initiation of low-dose hydrocortisone therapy for septic shock in geriatric patients: a randomized control trial","volume":"70","author":"Agarwal","year":"2022","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155750_bb0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/SHK.0000000000000665","article-title":"Effects of increasing hydrocortisone to 300mg per day in the treatment of septic shock: a pilot study","volume":"46","author":"Hyvernat","year":"2016","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s42077-022-00259-6","article-title":"Evaluation of the role of hydrocortisone either alone or combined with fludrocortisone in the outcome of septic shock in adults","volume":"14","author":"Labib","year":"2022","journal-title":"Ain-Shams J Anesthesiol"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155750_bb0145","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","article-title":"Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock","volume":"33","author":"Oppert","year":"2005","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155750_bb0150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0155","first-page":"718","article-title":"Early low-dose glucocorticoid therapy effectively suppresses serum pro-inflammatory factors such as IL-6 and inhibits apoptosis of CD4+ cells in septic shock patients","volume":"12","author":"Jiang","year":"2019","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15171\/jept.2017.25","article-title":"The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial","volume":"4","author":"Talebi Doluee","year":"2018","journal-title":"J Emerg Prac Trauma"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155750_bb0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/CCLM.2005.044","article-title":"Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock","volume":"43","author":"Mussack","year":"2005","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study","volume":"27","author":"Briegel","year":"1999","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155750_bb0185","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0b013e31816f48f2","article-title":"Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach","volume":"36","author":"Aboab","year":"2008","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155750_bb0190","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155750_bb0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155750_bb0205","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s00134-024-07616-z","article-title":"Fludrocortisone dose\u2013response relationship in septic shock: a randomised phase II trial","volume":"50","author":"Walsham","year":"2024","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155750_bb0210","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0215","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Crit Care Explor"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155750_bb0220","article-title":"The efficacy, safety, and optimal regimen of corticosteroids in sepsis: a Bayesian network meta-analysis","volume":"2","author":"Zhang","year":"2020","journal-title":"Crit Care Explor"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155750_bb0225","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","article-title":"Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: a systematic review and network meta-analysis of randomized controlled trials","volume":"209","author":"Teja","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155750_bb0230","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2020.01318","article-title":"Glucocorticoids in sepsis: to be or not to be","volume":"11","author":"Vandewalle","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcrc.2026.155750_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcrc.2020.12.001","article-title":"Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: a retrospective cohort study","volume":"62","author":"Bonnin","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2026.155750_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155750_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bja.2023.10.034","article-title":"Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective","volume":"132","author":"Nethathe","year":"2024","journal-title":"Br J Anaesth"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155750_bb0250","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic signatures in Sepsis and a differential response to steroids. From the VANISH randomized trial","volume":"199","author":"Antcliffe","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155750_bb0255","article-title":"A gene expression-based approach for the precision use of hydrocortisone in septic shock patients; a secondary analysis of the ADRENAL trial","volume":"27","author":"Venkatesh","year":"2025","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.jcrc.2026.155750_bb0260","article-title":"Glucocorticoid impaired the wound healing ability of endothelial progenitor cells by reducing the expression of CXCR4 in the PGE2 pathway","volume":"5","author":"Carolina","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155750_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155750_bb0270","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/aas.13159","article-title":"Corticosteroids and risk of gastrointestinal bleeding in critically ill adults: protocol for a systematic review","volume":"62","author":"Butler","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155750_bb0275","article-title":"Evolution of the concept of Sepsis","volume":"11","author":"Vincent","year":"2022","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412600328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412600328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:37:39Z","timestamp":1792766259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412600328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":55,"alternative-id":["S088394412600328X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155750","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of hydrocortisone-based regimens in septic shock: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155750"}}